

Author: Dodos Fotiní
Publisher: Springer Publishing Company
ISSN: 1861-0684
Source: Clinical Research in Cardiology, Vol.97, Iss.5, 2008-05, pp. : 318-326
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Genotyping the risk of anthracycline-induced cardiotoxicity
By Deng Shiwei Wojnowski Leszek
Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. :






Anthracycline-induced phospholipase A2 inhibition
By Swift Luther McHowat Jane Sarvazyan Narine
Cardiovascular Toxicology, Vol. 7, Iss. 2, 2007-06 ,pp. :